9 completed, 2 recruiting, 2 unknown, 2 withdrawn. 6 Phase 1, 6 Phase 2, 3 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 6 | Unknown 2, Withdrawn 2, Completed 1, Recruiting 1 |
| Phase 2 | 6 | Completed 5, Unknown 1 |
| Phase 3 | 3 | Completed 2, Recruiting 1 |
Follow GC Cell Corporation: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Phase 1 to Investigate the Safety, Tolerability, and Efficacy of GCC2005 in Patients With R/R NK and T-cell Malignancies GCC2005, Cyclophosphamide, Fludarabine - Lymphoma, T-Cell | Phase 1 | Recruiting | GC Cell Corporation | 53 | 2025-03-07 | 2026-07-24 |
| Phase 1 Clinical Trial to Evaluate the Safety and Anti-Tumor Activity of AB-201 AB-201, Cyclophosphamide, Fludarabine - Breast Cancer, Gastric Cancer | Phase 1 | Withdrawn | GC Cell Corporation | 2024-10-31 | 2025-01-24 | |
| Retrospective Study of Long-Term Survival of "Immuncell-LC" in Patients Undergoing Curative Resection for HCC in Korea Immuncell-LC, No Interventions - Hepatocellular Carcinoma | Completed | GC Cell Corporation | 230 | 2024-09-30 | 2025-08-15 | |
| Clinical Trial to Evaluate the Safety, Tolerability and Efficacy of CT303 in Patients With ARDS CT303 - Acute Respiratory Distress Syndrome | Phase 1 | Withdrawn | GC Cell Corporation | 2022-01-26 | 2023-04-04 | |
| Clinical Trial to Evaluate the Safety, Tolerability and Efficacy of CT303 in Patients With Psoriasis CT303 - Moderate to Severe Plaque Psoriasis | Phase 1 | Unknown | GC Cell Corporation | 24 | 2021-10-25 | 2022-03-18 |
| Safety and Efficacy of Immuncell-LC With Gemcitabine in Resectable Pancreatic Cancer Immuncell-LC, Gemcitabine - Pancreatic Ductal Adenocarcinoma | Phase 3 | Recruiting | GC Cell Corporation | 408 | 2021-09-07 | 2021-11-22 |
| Evaluate the Efficacy and Safety of 'Immuncell-LC' in Patients Undergoing Liver Transplantation Immuncell-LC - Liver Transplantation | Phase 1 / Phase 2 | Completed | GC Cell Corporation | 19 | 2019-01-24 | 2023-06-22 |
| MG4101 Plus Rituximab Including Lymphodepletion in Patient With r/r NHL B-cell Origin Rituximab, Fludarabine, Cyclophosphamide - Relapsed Non Hodgkin Lymphoma, Refractory Non-Hodgkin Lymphoma | Phase 1 / Phase 2 | Unknown | GC Cell Corporation | 9 | 2018-11-28 | 2020-07-28 |
| Safety and Efficacy of "Immuncell-LC" in TACE Therapy Immuncell-LC - Carcinoma, Hepatocellular | Phase 2 | Completed | GC Cell Corporation | 76 | 2018-05-28 | 2023-06-22 |
| A Study of MG4101 (Allogeneic Natural Killer Cell) for Intermediate-stage of Hepatocellular Carcinoma MG4101 - Hepatocellular Carcinoma | Phase 2 | Completed | GC Cell Corporation | 78 | 2016-11-28 | 2019-09-26 |
| Efficacy and Safety of 'Immuncell-LC Group' and 'Non-treatment Group' in Nexavar Treated Patients for Advanced HCC Immuncell-LC - Advanced Hepatocellular Carcinoma | Phase 2 | Completed | GC Cell Corporation | 40 | 2013-12-01 | 2023-06-26 |
| Long Term Follow-Up Study of Immuncell-LC Group and Non-Treatment Group in Hepatocellular Carcinoma Patients. Hepatocellular Carcinoma | Completed | GC Cell Corporation | 162 | 2013-06-01 | 2023-06-26 | |
| Evaluate the Efficacy and Safety of Activated T-lymphocyte Cell Therapy in Advanced Pancreatic Cancer Activated T lymphocyte - Pancreatic Cancer | Phase 2 | Completed | GC Cell Corporation | 20 | 2009-09-01 | 2023-07-19 |
| Clinical Trial to Assess the Efficacy and Safety of 'Immuncell-LC' With Temozolomide in Newly Diagnosed Glioblastoma of Korea Activated T lymphocyte(Immuncell-LC) - Glioblastoma | Phase 3 | Completed | GC Cell Corporation | 180 | 2008-12-05 | 2025-10-10 |
| Efficacy and Safety of Immuncell-LC Group and Non-treatment Group in Hepatocelluar Carcinoma Patients Immuncell-LC - Hepatocellular Carcinoma | Phase 3 | Completed | GC Cell Corporation | 230 | 2008-07-01 | 2023-07-11 |
Carcinoma, Hepatocellular (5) · Pancreatic Neoplasms (2) · Breast Neoplasms (1) · Glioblastoma (1) · Lymphoma, Non-Hodgkin (1) · Lymphoma, T-Cell (1) · Psoriasis (1) · Respiratory Distress Syndrome (1) · Stomach Neoplasms (1)
Cyclophosphamide (3) · fludarabine (3) · Gemcitabine (1) · Interleukin-2 (1) · Rituximab (1) · aldesleukin (1) · fludarabine phosphate (1)
South Korea (14)
Jung Hwan Yoon, MD (3) · Chunghyun Kim, MD (1) · JinHee Kang (1) · Jong Eun Yeon, MD (1) · Joon Hyeok Lee, MD (1) · Jung Hwan Yoon, M.D., Ph.D. (1) · Kyung Suk Suh, MD (1) · Sang Hyub Lee (1) · Seongjin Jo (1) · Siyoung Song, MD, PhD (1) · Soon Ho Um, MD, PhD (1) · Tae Gin Song, MD (1) · Won Seog Kim, Dr. (1) · Young-Jae Cho, MD, MPH, PhD (1) · Young-Suk Lim, MD (1)